ArticleTrials2020

Upfront radical surgery with total mesorectal excision followed by adjuvant FOLFOX chemotherapy for locally advanced rectal cancer (TME-FOLFOX): an open-label, multicenter, phase II randomized controlled trial.

Jii Bum Lee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.